Status:
COMPLETED
Patent Foramen Ovale Closure in Older Patients
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Collaborating Sponsors:
Toronto General Hospital
Montreal Heart Institute
Conditions:
Patent Foramen Ovale
Ischemic Stroke
Eligibility:
All Genders
60+ years
Brief Summary
* Describe the baseline and procedural characteristics of older patients undergoing PFO closure due to cryptogenic embolism. * Assess the long-term follow-up of this cohort, focusing on neurological e...
Detailed Description
In patients with cryptogenic stroke, up to 4 randomized trials and subsequent meta-analyses have recently shown a significant reduction in recurrent ischemic stroke events following percutaneous closu...
Eligibility Criteria
Inclusion
- Patients older than 60 years who have experienced a previous paradoxical embolism (stroke, transient ischaemic attack or peripheral embolism) of unknown origin and underwent transcatheter PFO closure.
Exclusion
- PFO closure indication other than paradoxical embolism (example: platypnea orthodeoxia syndrome).
- Surgical PFO closure.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04780022
Start Date
April 1 2021
End Date
December 1 2021
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRIUCPQ
Québec, Quebec, Canada, G1V 4G5